#EICSummit21 - Health and Biotech: Innovation potential of EIC beneficiaries through eyes of experts

A biotech investment firm CSO and a bio-processing national center CEO meet two promising EIC beneficiaries from different stages of development (Pathfinder and Accelerator).

Moderators: Iordanis Arzimanoglou, EIC Program Manager for Health and Biotechnology.
Speakers: Darrin Morrissey, CEO of NIBRT; Serge Pampfer, CSO of EureKare; Prof. Francesca M. Spagnoli, Professor in Regenerative Medicine, Group Leader in the Centre for Stem Cells and Regenerative Medicine; Dr. Evelina Vågesjö, Co-founder and CEO of Ilya Pharma.

In this session, the CSO of the biotech investment firm EureKare (Serge Pampfer) and the CEO of the Irish National Institute for Bioprocessing Research and Training NIBRT (Darrin Morrissey), will explore the innovation potential, uniqueness of the solution under development offered and commercial capabilities of two EIC funded Health and Biotech projects: Pan3DP (Pathfinder) and WHILYAS-2 (Accelerator grant+equity).

The two experts will constructively challenge the two EIC beneficiaries with scientific, innovation element, competitive landscape, targeted market and other questions including the potential impact of EIC funding in their current undertakings, in a dynamic and stimulating discussion, chaired by Iordanis Arzimanoglou, EIC Programme Manager on Health and Biotechnology.

Read more
Watch replay
Be the first to comment